Clinical Trials in North Carolina

Showing 1761-1780 of 9,731 trials

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

NCT04638660

The objectives of this study are: * To evaluate the efficacy of Nyxol to improve mesopic low contrast visual acuity (mLCVA) in subjects with Dim Light Vision Disturbances (DLD) * To evaluate efficacy of Nyxol to improve visual performance * To evaluate the safety of Nyxol

Dim Light Vision Disturbances

Ocuphire Pharma, Inc.144 participantsStarted Dec 2020

Newport Beach, California, United States • Petaluma, California, United States • Jacksonville, Florida, United States +14 more locations

COMPLETEDPhase 241 miles

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

NCT06176768

The main purpose of this study is to determine the efficacy and safety of LY3972406 in adult participants with moderate-to-severe plaque psoriasis.

Plaque Psoriasis

Eli Lilly and Company33 participantsStarted Dec 2023

Los Angeles, California, United States • Santa Monica, California, United States • Coral Gables, Florida, United States +9 more locations

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Find Trials by Condition in North Carolina

Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

CemiplimAb Survivorship Epidemiology

Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

A Study of Inhaled AZD8630 in Adolescents With Asthma

A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Longitudinal Study of Mitochondrial Hepatopathies

Biliary Atresia Study in Infants and Children

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants

A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia